Artelo Biosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $600.0K | $2.3M | $2.8M | $6.9M | $12.2M | $5.8M | $4.4M | $337.4K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $695.0K | $2.6M | $11.0M | $18.3M | $24.6M | $2.3M | $4.4M | $396.4K |
| Property, Plant & Equipment | — | — | — | — | — | $246 | $721 | $563 |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | — |
| Total Assets | $2.8M | $4.7M | $13.0M | $20.4M | $28.3M | $4.4M | $6.5M | $397.0K |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $4.0M | $1.8M | $1.3M | $998.0K | $1.0M | $501.0K | $1.0M | $532.0K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.1M | $1.8M | $1.3M | $1.0M | $1.1M | $501.0K | $1.0M | $532.0K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-63.0M | $-50.1M | $-40.3M | $-31.0M | $-20.9M | $-9.5M | $-4.8M | $-2.6M |
| Total Stockholders' Equity | $-1.3M | $2.9M | $11.8M | $19.4M | $27.2M | $8.4M | $5.5M | $-135.0K |